Safeguard Investment Advisory Group’s Milestone Pharmaceuticals MIST Stock Holding History

Safeguard Investment Advisory Group’s Portfolio MIST Stock Details MIST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$16.6K	Sell	12,406 -12,638	-50%	-$20.2K	﹤0.01%	178
2026 Q1	$29.8K	Hold	25,044	–	–	0.01%	142
2025 Q4	$50.6K	Hold	25,044	–	–	0.01%	148
2025 Q3	$50.1K	Hold	25,044	–	–	0.01%	150
2025 Q2	$48.6K	Hold	25,044	–	–	0.01%	143
2025 Q1	$20K	Buy	+25,044	New	+$49.8K	0.01%	140

Other funds holding MIST

PCM

Pavaki Capital Management Pueblo, Colorado $287M AUM

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $191M AUM 102.42% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

KCM

Kalehua Capital Management Dallas, Texas $174M AUM

LPC

Lion Point Capital New York $20.9M AUM 195.52% 1-Year Est. Return

Safeguard Investment Advisory Group's MIST Position: Q2 2026 in Review

Safeguard Investment Advisory Group reduced its Milestone Pharmaceuticals (MIST) stake by 50% in Q2 2026, selling an estimated $20.2K and leaving 12,406 shares worth $16.6K. The position accounts for ﹤0.01% of the portfolio, ranked #178.

Safeguard Investment Advisory Group first reported a position in MIST in Q1 2025 and has held it in 6 quarters since. The position peaked at $50.6K in Q4 2025. 78 funds tracked by Wall St. Rank hold MIST as of Q2 2026.

Safeguard Investment Advisory Group held 12,406 shares of Milestone Pharmaceuticals worth $16.6K as of Q2 2026.
Safeguard Investment Advisory Group sold 12,638 Milestone Pharmaceuticals shares in Q2 2026, an estimated $20.2K.
Milestone Pharmaceuticals made up ﹤0.01% of Safeguard Investment Advisory Group's portfolio in Q2 2026, its #178 holding.
Safeguard Investment Advisory Group first reported a position in Milestone Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
Safeguard Investment Advisory Group's Milestone Pharmaceuticals position peaked at $50.6K in Q4 2025.
78 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q2 2026.

Based on Safeguard Investment Advisory Group's 13F filing for Q2 2026, filed 13 Aug 2026.